These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 575181)
41. Illicit drug use should not be legalized. Rosner F; Wolpaw J; Sechzer PH; Rogatz P; Risemberg HM; Ona FV; Numann PJ; Lowenstein R; Loeb L; Landolt AB N Y State J Med; 1992 Feb; 92(2):59-62. PubMed ID: 1565313 [No Abstract] [Full Text] [Related]
42. [Use and control of psychotropic drugs is given priorty in Scandinavian drug research]. Karlsson Y Nord Med; 1977 Mar; 92(3):90-2. PubMed ID: 557789 [No Abstract] [Full Text] [Related]
43. Legislative harassment of physicians and researchers. Chayet NL N Engl J Med; 1971 Dec; 285(23):1319-20. PubMed ID: 5165402 [No Abstract] [Full Text] [Related]
44. [Natural extracts for injections--available?]. Eckerdal G Lakartidningen; 2000 Jul; 97(28-29):3296. PubMed ID: 10997025 [No Abstract] [Full Text] [Related]
45. [Phenylethylamine--a hazardous substitute for amphetamine in the narcotics market]. Ortman E; Steen G Lakartidningen; 1973 Jan; 70(2):118-9. PubMed ID: 4683502 [No Abstract] [Full Text] [Related]
47. The DEA proposes schedule II substance rule. Buchanan BL WMJ; 2007 Jul; 106(4):230. PubMed ID: 17844715 [No Abstract] [Full Text] [Related]
48. Controlled substances registration for nonlicensed physicians. Alexander V; Lazarus H; McGovern H Hospitals; 1978 Oct; 52(19):165-6, 168, 170. PubMed ID: 689606 [TBL] [Abstract][Full Text] [Related]
49. Regulating opioid prescribing through prescription monitoring programs: balancing drug diversion and treatment of pain. Fishman SM; Papazian JS; Gonzalez S; Riches PS; Gilson A Pain Med; 2004 Sep; 5(3):309-24. PubMed ID: 15367312 [TBL] [Abstract][Full Text] [Related]
50. Drugs and dentistry...balancing power and responsibility. Cross J Dent Stud; 1981 Apr; 59(7):58, 60-2, 64-5. PubMed ID: 6949814 [No Abstract] [Full Text] [Related]
51. Drugs and drugged behavior: medicolegal considerations. Cohen S J Clin Pharmacol J New Drugs; 1969; 9(1):5-11. PubMed ID: 5250313 [No Abstract] [Full Text] [Related]
52. Fourth special session of the Commission on Narcotic Drugs. Bull Narc; 1976; 28(4):1-16. PubMed ID: 1051621 [No Abstract] [Full Text] [Related]
53. Impact of legislation upon drug abuse. Melton MW Am J Pharm Sci Support Public Health; 1970; 142(4):156-60. PubMed ID: 5514562 [No Abstract] [Full Text] [Related]
54. Drug abuse legislation for the 1970's. Pediatrics; 1971 Dec; 48(6):990-2. PubMed ID: 5129461 [No Abstract] [Full Text] [Related]
55. [Changes of directives on the requesting and distribution of drugs from pharmacies]. Sigurdsen M; Nordahl H Tidsskr Nor Laegeforen; 1975 Apr; 95(12):781-2. PubMed ID: 1145551 [No Abstract] [Full Text] [Related]
56. Programs for monitoring inappropriate prescribing of controlled drugs: evaluation and recommendations. Collins TM; Zimmerman DR Am J Hosp Pharm; 1992 Jul; 49(7):1765-8. PubMed ID: 1621738 [No Abstract] [Full Text] [Related]
57. Drugs and the dental profession. Fishman AM Ohio Dent J; 1987; 61(4):53-7. PubMed ID: 3472131 [No Abstract] [Full Text] [Related]
58. [Drugs]. Greppin R Z Krankenpfl; 1972 Dec; 65(12):446-51. PubMed ID: 4486551 [No Abstract] [Full Text] [Related]
59. Guidelines for prescribers of controlled drugs. Phillips D J Ark Med Soc; 1985 Feb; 81(9):463-4. PubMed ID: 3156117 [No Abstract] [Full Text] [Related]
60. Criminal laws and the control of drugs of abuse. An historical view of the law (or, it's the lawyer's fault). Hollister LE J Clin Pharmacol J New Drugs; 1969; 9(6):345-8. PubMed ID: 4900515 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]